Disclosures for "Post-loading (Day 3) Platelet CXCR7 Predicts Long-term Vascular Recurrence After Ischemic Stroke: A Prospective Cohort Study"
-
Kevin Soon Hwee Teo, MA, MB, BChir, MRCP has nothing to disclose.
-
Dr. TENG has nothing to disclose.
-
Ms. Er has nothing to disclose.
-
The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca.
-
Dr. Seet has nothing to disclose.